Literature DB >> 4435025

Pharmacological evidence for a vasodilator receptor to serotonin in the nasal vessels of the dog.

B B Vargaftig, J Lefort.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4435025     DOI: 10.1016/0014-2999(74)90053-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  8 in total

Review 1.  Aspects of release of pharmacologically active substances from the lungs by chemical stimuli.

Authors:  B B Vargaftig
Journal:  Agents Actions       Date:  1976-07

2.  Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine.

Authors:  E Müller-Schweinitzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

3.  A new in vitro method of drug assay of nasal blood vessels.

Authors:  R T Jackson
Journal:  Arch Otorhinolaryngol       Date:  1979

4.  Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature.

Authors:  E Apperley; W Feniuk; P P Humphrey; G P Levy
Journal:  Br J Pharmacol       Date:  1980-02       Impact factor: 8.739

5.  Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein.

Authors:  W Feniuk; P P Humphrey; A D Watts
Journal:  Br J Pharmacol       Date:  1979-10       Impact factor: 8.739

6.  Effects of 5-hydroxytryptamine and related compounds on the sympathetic nerves of the rabbit heart.

Authors:  M Göthert; U Dührsen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

7.  Effects of mianserin, desipramine and maprotiline on blood pressure responses evoked by acetylcholine, histamine and 5-hydroxytryptamine in rats.

Authors:  I Cavero; F Lefèvre-Borg; A G Roach
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

8.  5-Hydroxytryptamine induces relaxation of goat pulmonary veins: evidence for the noninvolvement of M and D-tryptamine receptors.

Authors:  N Chand
Journal:  Br J Pharmacol       Date:  1981-02       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.